Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$58.02 -0.34 (-0.58%)
At close: Oct 23, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Asset Writedowns and Impairment (2012 - 2013)

Updated

Arrowhead Pharmaceuticals (ARWR) reported Asset Writedowns and Impairment of $2.05 million for FY2016 (year ended Sep 30, 2016).

Analysis

Arrowhead Pharmaceuticals (ARWR) Asset Writedowns and Impairment (2012 - 2013) Analysis & Trends

  • According to Business Quant data, Asset Writedowns and Impairment came in at $2.17 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Arrowhead Pharmaceuticals 8.35 Bn 3.13 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 1.04 Mn
Sep 30, 2012 187,000.00
API Access

Arrowhead Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ARWR&period=max&api_key=YOUR_API_KEY